-
Wegovy and Ozempic Patients Get Compensation for NAION Vision Loss In Europe
Because Semaglutide is Linked to NAION, Wegovy and Ozempic Drug Injury Cases Have Been Filed In the US (Posted by Tom Lamb at Drug Injury Watch) For more than a year now, we have been looking into…
-
Depo-Provera Meningioma Cases: Women With At Least 4 Years Use or Starting Injections After Age 31
Higher Risk Of Meningioma Side Effects Associated With Depo-Provera for These Women, According to a 2025 Medical Study Report (Posted by Tom Lamb at Drug Injury Watch) A recent medical study looking at Depo-Provera meningioma cases in…
-
Wegovy and Ozempic Increase NAION Risk, an Eye Side Effect That Can Result in Blindness
Semaglutide is the Active Ingredient in These GLP-1 Drugs Used for Diabetes or Weight Loss (Posted by Tom Lamb at Drug Injury Watch) Over the past year, we have written several articles that reference medical reports concerning…
-
Dupixent Lawsuits Being Filed for Patients: Medical Information and Legal Allegations
These Dupixent Cases Involving T-cell Lymphoma Cancer Are Against Regeneron Pharmaceuticals and Sanofi-Aventis (Posted by Tom Lamb at Drug Injury Watch) We are currently investigating possible Dupixent lawsuits for patients who were diagnosed with a relatively rare…
-
Dupixent Drug Injury Lawsuits For Patients Diagnosed With CTCL Cancer
Cutaneous T-cell Lymphoma (CTCL) Cancer Includes Mycosis Fungoides And Sézary Syndrome (Posted by Tom Lamb at Drug Injury Watch) A growing body of medical evidence showing an association between Dupixent and cutaneous T-cell lymphoma (CTCL) has given…
-
More Evidence For Increased Risk of NAION With Ozempic or Mounjaro in Diabetes Patients
NAION is Likely Associated With Other Semaglutide or Tirzepatide GLP-1RA Drugs Used for Weight Loss (Posted by Tom Lamb at Drug Injury Watch) A new medical article published August 11, 2025, online by JAMA Network…
